CONDITIONAL SHARE PURCHASE AGREEMENTConditional Share Purchase Agreement • December 22nd, 2015 • CareDx, Inc. • Services-medical laboratories • Stockholm
Contract Type FiledDecember 22nd, 2015 Company Industry JurisdictionThis Conditional Share Purchase Agreement (this “Agreement”) has, on the date hereof, been entered into by and between CareDx, Inc. (the “Purchaser”) and FastPartner AB (the “Seller”).
Company Registration Number: 196800320E)Conditional Share Purchase Agreement • April 21st, 2014
Contract Type FiledApril 21st, 2014CONDITIONAL SHARE PURCHASE AGREEMENT IN RELATION TO THE PROPOSED ACQUISITION OF THE ENTIRED ISSUED AND PAID UP SHARE CAPITAL OF STRAITS CONSTRUCTION GROUP PTE LTD – A VERY SUBSTANTIAL ACQUISITION OR REVERSE TAKEOVER
SECOND AMENDMENT TO CONDITIONAL SHARE PURCHASE AGREEMENTConditional Share Purchase Agreement • January 23rd, 2017 • CareDx, Inc. • Services-medical laboratories • Stockholm
Contract Type FiledJanuary 23rd, 2017 Company Industry JurisdictionThis Second Amendment (this “Amendment”) is entered into by and between CareDx, Inc. (the “Purchaser”) and FastPartner AB (the “Seller”) and amends that certain Conditional Purchase Agreement, as amended (the “Agreement”) between the Purchaser and the Seller relating to the sale by the Seller and the purchase by the Purchaser of all of the Seller’s 38,886,307 shares in Allenex AB (the “Company”) in connection with the Purchaser’s public offer to acquire all outstanding shares in the Company announced by the Purchaser on 16 December 2015. Terms used but not defined herein shall have the meaning ascribed thereto in the Agreement.
SECOND AMENDMENT TO CONDITIONAL SHARE PURCHASE AGREEMENTConditional Share Purchase Agreement • January 23rd, 2017 • CareDx, Inc. • Services-medical laboratories • Stockholm
Contract Type FiledJanuary 23rd, 2017 Company Industry JurisdictionThis Second Amendment (this “Amendment”) is entered into by and between CareDx, Inc. (the “Purchaser”) and Xenella Holding AB (the “Seller”) and amends that certain Conditional Purchase Agreement, as amended (the “Agreement”) between the Purchaser and the Seller relating to the sale by the Seller and the purchase by the Purchaser of all of the Seller’s 11,174,755 shares in Allenex AB (the “Company”) in connection with the Purchaser’s public offer to acquire all outstanding shares in the Company announced by the Purchaser on 16 December 2015. Terms used but not defined herein shall have the meaning ascribed thereto in the Agreement.
CONDITIONAL SHARE PURCHASE AGREEMENTConditional Share Purchase Agreement • April 22nd, 2022 • Genius Group LTD • Services-educational services
Contract Type FiledApril 22nd, 2022 Company IndustryGenius Group Ltd (the “Purchaser”), a public company duly organised and operating under the Laws of Singapore under registration number 201541844C, having its registered seat at 8 Amoy Street, #01-01 Singapore 049950 represented by Roger James Hamilton
AMENDMENT TO CONDITIONAL SHARE PURCHASE AGREEMENTConditional Share Purchase Agreement • February 12th, 2016 • CareDx, Inc. • Services-medical laboratories • Stockholm
Contract Type FiledFebruary 12th, 2016 Company Industry JurisdictionThis Amendment (this “Amendment”) is entered into by and between CareDx, Inc. (the “Purchaser”) and Midroc Invest AB (the “Seller”) and amends that certain Conditional Purchase Agreement (the “Agreement”) between the Purchaser and the Seller relating to the sale by the Seller and the purchase by the Purchaser of all of the Seller’s 43,678,850 shares in Allenex AB (the “Company”) in connection with the Purchaser’s public offer to acquire all outstanding shares in the Company announced by the Purchaser on 16 December 2015. Terms used but not defined herein shall have the meaning ascribed thereto in the Agreement.
AMENDMENT TO CONDITIONAL SHARE PURCHASE AGREEMENTConditional Share Purchase Agreement • February 12th, 2016 • CareDx, Inc. • Services-medical laboratories • Stockholm
Contract Type FiledFebruary 12th, 2016 Company Industry JurisdictionThis Amendment (this “Amendment”) is entered into by and between CareDx, Inc. (the “Purchaser”) and FastPartner AB (the “Seller”) and amends that certain Conditional Purchase Agreement (the “Agreement”) between the Purchaser and the Seller relating to the sale by the Seller and the purchase by the Purchaser of all of the Seller’s 38,886,307 shares in Allenex AB (the “Company”) in connection with the Purchaser’s public offer to acquire all outstanding shares in the Company announced by the Purchaser on 16 December 2015. Terms used but not defined herein shall have the meaning ascribed thereto in the Agreement.
AMENDMENT TO CONDITIONAL SHARE PURCHASE AGREEMENTConditional Share Purchase Agreement • February 12th, 2016 • CareDx, Inc. • Services-medical laboratories • Stockholm
Contract Type FiledFebruary 12th, 2016 Company Industry JurisdictionThis Amendment (this “Amendment”) is entered into by and between CareDx, Inc. (the “Purchaser”) and Xenella Holding AB (the “Seller”) and amends that certain Conditional Purchase Agreement (the “Agreement”) between the Purchaser and the Seller relating to the sale by the Seller and the purchase by the Purchaser of all of the Seller’s 11,174,755 shares in Allenex AB (the “Company”) in connection with the Purchaser’s public offer to acquire all outstanding shares in the Company announced by the Purchaser on 16 December 2015. Terms used but not defined herein shall have the meaning ascribed thereto in the Agreement.
SECOND AMENDMENT TO CONDITIONAL SHARE PURCHASE AGREEMENTConditional Share Purchase Agreement • January 23rd, 2017 • CareDx, Inc. • Services-medical laboratories • Stockholm
Contract Type FiledJanuary 23rd, 2017 Company Industry JurisdictionThis Second Amendment (this “Amendment”) is entered into by and between CareDx, Inc. (the “Purchaser”) and Midroc Invest AB (the “Seller”) and amends that certain Conditional Purchase Agreement, as amended (the “Agreement”) between the Purchaser and the Seller relating to the sale by the Seller and the purchase by the Purchaser of all of the Seller’s 43,678,850 shares in Allenex AB (the “Company”) in connection with the Purchaser’s public offer to acquire all outstanding shares in the Company announced by the Purchaser on 16 December 2015. Terms used but not defined herein shall have the meaning ascribed thereto in the Agreement.